Evaluation of the steroid ointment utility to prevent the injection site reactions and phlebitis caused by vinorelbine.

Evaluation of the steroid ointment utility to prevent the injection site reactions and phlebitis caused by vinorelbine. - Prevention of the vinorelbine phlebitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001065

Enrollment

Registered

2012-12-31

Start date

2007-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

steroid ointment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cancer patient treated by Navelbine Good organ functions More than 2months survival

Exclusion criteria

Exclusion criteria: Hypersensivity to steroid ointment. Treating with steroid. Having no adequate vessel to observe phlebitis.

Design outcomes

Primary

Measure	Time frame
phlebitis	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026